25 APRIL 2018 UPDATE:

Availability of EpiPen^® 0.3mg Adrenaline Auto-Injector

Overview

Due to manufacturing delays from our contract manufacturer, Meridian Medical Technologies, a Pfizer company, there are intermittent supply constraints on EpiPen^® 0.3mg Adrenaline Auto-Injector in the UK.

Latest Supply Status

Our UK distribution partner, Alliance Healthcare, has received additional stock of EpiPen® 0.3mg Adrenaline Auto-Injector from Pfizer and they will be working with pharmacies to fulfil prescriptions.

To further assist in the stock management of EpiPen® 0.3mg, pharmacies are allocated stock on a prescription-only basis and can place orders for up to a maximum of two EpiPen® 0.3mg Auto-Injectors per prescription.

With patient access as our priority, we will continue to proactively and diligently update pharmacies, healthcare professionals and patient advocacy groups across the country regarding any changes in stock availability. 

There are currently sufficient supplies of EpiPen Jr^®  0.15mg Adrenaline Auto-Injectors in the UK.

Ongoing Supply Management

Mylan is working closely with Pfizer to manage supply carefully to avoid long-term supply shortages. Pfizer anticipates that production rates will increase over the coming months; however, at this time, cannot commit to a specific time for when the supply constraint will be fully resolved. We are confident in the safety and efficacy of the EpiPen® products being produced at Pfizer’s site and are working closely with them to alleviate the situation and achieve a steady state of supply as expeditiously as possible.

Information for Patients

Mylan is unable to make any specific treatment recommendation to individual patients. Patients should speak to their healthcare provider for appropriate actions to be taken.

Information for Prescribers

Please note, when validating the expiry date of an adrenaline auto-injector, the product expires on the last day of the month indicated. For example, if it expires in April, it remains valid (not expired) until April 30.

Contact Information

If you require additional information or have any questions, please contact +44(0) 1707 853 100.

Choose the right site for you